fexofenadine has been researched along with Mastocytosis, Systemic in 1 studies
fexofenadine: a second generation antihistamine; metabolite of the antihistaminic drug terfenadine; structure in first source; RN refers to HCl
fexofenadine : A piperidine-based anti-histamine compound.
Mastocytosis, Systemic: A group of disorders caused by the abnormal proliferation of MAST CELLS in a variety of extracutaneous tissues including bone marrow, liver, spleen, lymph nodes, and gastrointestinal tract. Systemic mastocytosis is commonly seen in adults. These diseases are categorized on the basis of clinical features, pathologic findings, and prognosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Urolithiasis is expected to cause a considerable complication in patients with systemic mastocytosis." | 1.35 | Ureteral stones due to systemic mastocytosis: diagnostic and therapeutic characteristics. ( Homann, J; Kolck, UW; Molderings, GJ; Schröder, D; Solleder, G; von Kügelgen, I; Vorreuther, R, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Molderings, GJ | 1 |
| Solleder, G | 1 |
| Kolck, UW | 1 |
| Homann, J | 1 |
| Schröder, D | 1 |
| von Kügelgen, I | 1 |
| Vorreuther, R | 1 |
1 other study available for fexofenadine and Mastocytosis, Systemic
| Article | Year |
|---|---|
Ureteral stones due to systemic mastocytosis: diagnostic and therapeutic characteristics.
Topics: Diagnosis, Differential; Glucocorticoids; Histamine H1 Antagonists, Non-Sedating; Histamine H2 Antag | 2009 |